Tumor-infiltrating immune cells were analyzed, and the NAPSL.p@OVA groups showed significantly increased CD3+CD4+ and CD3+CD8+ T cell infiltration in tumor tissues compared to the control group (Fig. 6f, g and Supplementary Figs. 26, 27). This evidence concerns the gene CD4 and neoplasm.